This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biotempt B.v.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Nisar Asmed Khan: Innovator in Gene Control and Inflammation Treatment
Introduction
Nisar Asmed Khan is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of gene expression modulation, particularly in relation to inflammation treatment. His innovative work has the potential to impact various medical applications.
Latest Patents
Nisar holds a patent for an invention titled "Oligopeptide treatment of NF-κB mediated inflammation." This invention focuses on the modulation of gene expression in cells, specifically targeting the treatment of anthrax. The method involves providing a cell with a signaling molecule that comprises a peptide or a functional analogue thereof, thereby influencing gene control.
Career Highlights
Nisar Asmed Khan is associated with Biotempt B.V., where he applies his expertise in biotechnology and gene modulation. His work at the company emphasizes the importance of innovative solutions in addressing complex health issues.
Collaborations
Nisar collaborates with Robert Benner, contributing to advancements in their field through shared knowledge and expertise.
Conclusion
Nisar Asmed Khan's contributions to gene expression modulation and inflammation treatment highlight his role as an innovator in biotechnology. His patent and work at Biotempt B.V. reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile